In the news


November 12, 2013

Indiana Clinical and Translational Sciences Institute receives $30 million grant renewal

The Indiana Clinical and Translational Sciences Institute, a partnership among Indiana University, Purdue University and the University of Notre Dame, has received nearly $30 million from the National Institutes of Health to continue its mission accelerating research discoveries across Indiana and beyond. The Clinical and Translational Sciences Award from the NIH's National Center for Advancing Translational Sciences renews the grant that established the Indiana CTSI five years ago, guaranteeing the institution will advance innovative health care programs and biomedical research into at least 2018.
March 13, 2013

Purdue’s growing drug development focus to strengthen Indiana CTSI

When the National Institutes of Health created the National Center for Advancing Translational Sciences, which houses the Clinical and Translational Sciences Award program that supports the Indiana Clinical and Translational Sciences Institute, NIH Director Francis Collins pinpointed accelerating the development of diagnostics and therapeutics as an important goal of the new center. Meanwhile, Purdue University, an institutional member of the Indiana CTSI along with Indiana University and the University of Notre Dame, is emerging as a leader in the field of drug discovery with construction underway on a new $25-million Drug Discovery Building, opening in 2014, and a new virtual center aimed at discovering new treatments for conditions such as cancer and inflammatory disease.